| Year |
Citation |
Score |
| 2015 |
Chang CW, Chiang CW, Gaffaney JD, Chapman ER, Jackson MB. Lipid-anchored synaptobrevin provides little or no support for exocytosis or liposome fusion. The Journal of Biological Chemistry. PMID 26663078 DOI: 10.1074/Jbc.M115.701169 |
0.623 |
|
| 2015 |
Xue R, Gaffaney JD, Chapman ER. Structural elements that underlie Doc2β function during asynchronous synaptic transmission. Proceedings of the National Academy of Sciences of the United States of America. 112: E4316-25. PMID 26195798 DOI: 10.1073/Pnas.1502288112 |
0.703 |
|
| 2014 |
Gaffaney JD, Xue R, Chapman ER. Mutations that disrupt Ca²âº-binding activity endow Doc2β with novel functional properties during synaptic transmission. Molecular Biology of the Cell. 25: 481-94. PMID 24356452 DOI: 10.1091/Mbc.E13-10-0571 |
0.695 |
|
| 2014 |
Gaffaney JD, Shetty M, Felts B, Pramod AB, Foster JD, Henry LK, Vaughan RA. Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge. Neurochemistry International. 73: 16-26. PMID 24269640 DOI: 10.1016/J.Neuint.2013.11.003 |
0.657 |
|
| 2012 |
Yao J, Kwon SE, Gaffaney JD, Dunning FM, Chapman ER. Uncoupling the roles of synaptotagmin I during endo- and exocytosis of synaptic vesicles. Nature Neuroscience. 15: 243-9. PMID 22197832 DOI: 10.1038/Nn.3013 |
0.695 |
|
| 2011 |
Yao J, Gaffaney JD, Kwon SE, Chapman ER. Doc2 is a Ca2+ sensor required for asynchronous neurotransmitter release. Cell. 147: 666-77. PMID 22036572 DOI: 10.1016/J.Cell.2011.09.046 |
0.752 |
|
| 2011 |
Hui E, Gaffaney JD, Wang Z, Johnson CP, Evans CS, Chapman ER. Mechanism and function of synaptotagmin-mediated membrane apposition. Nature Structural & Molecular Biology. 18: 813-21. PMID 21642967 DOI: 10.1038/Nsmb.2075 |
0.739 |
|
| 2008 |
Gaffaney JD, Dunning FM, Wang Z, Hui E, Chapman ER. Synaptotagmin C2B domain regulates Ca2+-triggered fusion in vitro: critical residues revealed by scanning alanine mutagenesis. The Journal of Biological Chemistry. 283: 31763-75. PMID 18784080 DOI: 10.1074/Jbc.M803355200 |
0.742 |
|
| 2008 |
Parnas ML, Gaffaney JD, Zou MF, Lever JR, Newman AH, Vaughan RA. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites. Molecular Pharmacology. 73: 1141-50. PMID 18216182 DOI: 10.1124/Mol.107.043679 |
0.713 |
|
| 2005 |
Vaughan RA, Parnas ML, Gaffaney JD, Lowe MJ, Wirtz S, Pham A, Reed B, Dutta SM, Murray KK, Justice JB. Affinity labeling the dopamine transporter ligand binding site. Journal of Neuroscience Methods. 143: 33-40. PMID 15763134 DOI: 10.1016/J.Jneumeth.2004.09.022 |
0.706 |
|
| 2004 |
Gaffaney JD, Vaughan RA. Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter. Molecular Pharmacology. 65: 692-701. PMID 14978248 DOI: 10.1124/Mol.65.3.692 |
0.657 |
|
| 2001 |
Vaughan RA, Gaffaney JD, Lever JR, Reith ME, Dutta AK. Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains. Molecular Pharmacology. 59: 1157-64. PMID 11306699 DOI: 10.1124/Mol.59.5.1157 |
0.671 |
|
| 2001 |
Dutta AK, Fei XS, Vaughan RA, Gaffaney JD, Wang N, Lever JR, Reith ME. Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label. Life Sciences. 68: 1839-49. PMID 11292062 DOI: 10.1016/S0024-3205(01)00981-X |
0.625 |
|
| Show low-probability matches. |